138 related articles for article (PubMed ID: 20652058)
1. Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction.
Fardin P; Cornero A; Barla A; Mosci S; Acquaviva M; Rosasco L; Gambini C; Verri A; Varesio L
J Biomed Biotechnol; 2010; 2010():878709. PubMed ID: 20652058
[TBL] [Abstract][Full Text] [Related]
2. The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.
Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Varesio L
BMC Genomics; 2009 Oct; 10():474. PubMed ID: 19832978
[TBL] [Abstract][Full Text] [Related]
3. A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.
Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Versteeg R; Caron HN; Molenaar JJ; Ora I; Eva A; Puppo M; Varesio L
Mol Cancer; 2010 Jul; 9():185. PubMed ID: 20624283
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
Applebaum MA; Jha AR; Kao C; Hernandez KM; DeWane G; Salwen HR; Chlenski A; Dobratic M; Mariani CJ; Godley LA; Prabhakar N; White K; Stranger BE; Cohn SL
Oncotarget; 2016 Nov; 7(47):76816-76826. PubMed ID: 27765905
[TBL] [Abstract][Full Text] [Related]
5. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.
Rellinger EJ; Romain C; Choi S; Qiao J; Chung DH
Pediatr Blood Cancer; 2015 Apr; 62(4):581-6. PubMed ID: 25630799
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent changes in ARE-driven gene expression by use of a noise-filtering process for microarray data.
Li J; Johnson JA
Physiol Genomics; 2002; 9(3):137-44. PubMed ID: 12045294
[TBL] [Abstract][Full Text] [Related]
7. Artificial neural network classifier predicts neuroblastoma patients' outcome.
Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577
[TBL] [Abstract][Full Text] [Related]
8. Impact of supervised gene signatures of early hypoxia on patient survival.
Seigneuric R; Starmans MH; Fung G; Krishnapuram B; Nuyten DS; van Erk A; Magagnin MG; Rouschop KM; Krishnan S; Rao RB; Evelo CT; Begg AC; Wouters BG; Lambin P
Radiother Oncol; 2007 Jun; 83(3):374-82. PubMed ID: 17532074
[TBL] [Abstract][Full Text] [Related]
9. PCA disjoint models for multiclass cancer analysis using gene expression data.
Bicciato S; Luchini A; Di Bello C
Bioinformatics; 2003 Mar; 19(5):571-8. PubMed ID: 12651714
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
11. Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro.
Sørensen BS; Toustrup K; Horsman MR; Overgaard J; Alsner J
Acta Oncol; 2010 Oct; 49(7):895-905. PubMed ID: 20429727
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional adaptation of neuroblastoma cells to hypoxia.
Fredlund E; Ovenberger M; Borg K; Påhlman S
Biochem Biophys Res Commun; 2008 Feb; 366(4):1054-60. PubMed ID: 18155155
[TBL] [Abstract][Full Text] [Related]
13. mtDNA as a Mediator for Expression of Hypoxia-Inducible Factor 1α and ROS in Hypoxic Neuroblastoma Cells.
Kuo CW; Tsai MH; Lin TK; Tiao MM; Wang PW; Chuang JH; Chen SD; Liou CW
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590414
[TBL] [Abstract][Full Text] [Related]
14. HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia.
Cimmino F; Avitabile M; Lasorsa VA; Montella A; Pezone L; Cantalupo S; Visconte F; Corrias MV; Iolascon A; Capasso M
BMC Med Genet; 2019 Feb; 20(1):37. PubMed ID: 30808328
[TBL] [Abstract][Full Text] [Related]
15. The L(1/2) regularization approach for survival analysis in the accelerated failure time model.
Chai H; Liang Y; Liu XY
Comput Biol Med; 2015 Sep; 64():283-90. PubMed ID: 25262114
[TBL] [Abstract][Full Text] [Related]
16. Hydra: A mixture modeling framework for subtyping pediatric cancer cohorts using multimodal gene expression signatures.
Pfeil J; Sanders LM; Anastopoulos I; Lyle AG; Weinstein AS; Xue Y; Blair A; Beale HC; Lee A; Leung SG; Dinh PT; Shah AT; Breese MR; Devine WP; Bjork I; Salama SR; Sweet-Cordero EA; Haussler D; Vaske OM
PLoS Comput Biol; 2020 Apr; 16(4):e1007753. PubMed ID: 32275708
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-mediated histone acetylation and expression of N-myc transcription factor dictate aggressiveness of neuroblastoma cells.
Poljaková J; Groh T; Gudino ZO; Hraběta J; Bořek-Dohalská L; Kizek R; Doktorová H; Eckschlager T; Stiborová M
Oncol Rep; 2014 Apr; 31(4):1928-34. PubMed ID: 24481548
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors.
Ognibene M; Cangelosi D; Morini M; Segalerba D; Bosco MC; Sementa AR; Eva A; Varesio L
PLoS One; 2017; 12(11):e0187206. PubMed ID: 29117193
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.
Meng X; Feng C; Fang E; Feng J; Zhao X
J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778
[TBL] [Abstract][Full Text] [Related]
20. Gene Expression Signatures as Biomarkers of Tumour Hypoxia.
Harris BH; Barberis A; West CM; Buffa FM
Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):547-60. PubMed ID: 26282471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
